D. J. Hoban
- Molecular Medicine top 0.2%
- Epidemiology top 2%
- Pharmacology top 1%
- Infectious Diseases top 2%
- Clinical Biochemistry top 1%
- Co-authors
- George G. ZhanelJames A. KarlowskyAndrew WalktyPhilippe Lagacé‐WiensKimberly A. NicholM. Roussel‐DelvallezG V DoernRonald N. Jones
- Topics
- Antibiotic Resistance in Bacteria (45 papers)Antibiotics Pharmacokinetics and Efficacy (39 papers)Pneumonia and Respiratory Infections (24 papers)
- Journals
- Clinical Infectious DiseasesJournal of Clinical MicrobiologyThe Journal of Infectious Diseases
- Partner nations
- CanadaUnited StatesUnited Kingdom
In The Last Decade
D. J. Hoban
74 papers receiving 2.4k citations
Peers
Comparison fields: 5 of 115
- Molecular Medicine 1.3k
- Epidemiology 1.2k
- Pharmacology 909
- Infectious Diseases 645
- Clinical Biochemistry 389
Countries citing papers authored by D. J. Hoban
This map shows the geographic impact of D. J. Hoban's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D. J. Hoban with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D. J. Hoban more than expected).
Fields of papers citing papers by D. J. Hoban
This network shows the impact of papers produced by D. J. Hoban. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D. J. Hoban. The network helps show where D. J. Hoban may publish in the future.
Co-authorship network of co-authors of D. J. Hoban
This figure shows the co-authorship network connecting the top 25 collaborators of D. J. Hoban. A scholar is included among the top collaborators of D. J. Hoban based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with D. J. Hoban. D. J. Hoban is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 27 | |
| 2 | 10 | |
| 3 | 21 | |
| 4 | 9 | |
| 5 | 38 | |
| 6 | 118 | |
| 7 | 37 | |
| 8 | 7 | |
| 9 | 27 | |
| 10 | 3 | |
| 11 | 1 | |
| 12 | 13 | |
| 13 | 18 | |
| 14 | 18 | |
| 15 | 323 | |
| 16 | 27 | |
| 17 | Value of routine procurement of Isolator in addition to BacT/Alert blood cultures in febrile neutropenic patients with acute myeloid leukemia | 1 |
| 18 | 23 | |
| 19 | 9 | |
| 20 | 5 |
About D. J. Hoban
D. J. Hoban is a scholar working on Molecular Medicine, Applied Microbiology and Biotechnology and Pharmacology, having authored 75 papers that have together received 2.6k indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (45 papers), Antibiotics Pharmacokinetics and Efficacy (39 papers) and Pneumonia and Respiratory Infections (24 papers). The work is most often cited by research in Molecular Medicine (1.3k citations), Applied Microbiology and Biotechnology (356 citations) and Clinical Biochemistry (389 citations). D. J. Hoban has collaborated with scholars based in Canada, United States and United Kingdom. Frequent co-authors include George G. Zhanel, James A. Karlowsky, Andrew Walkty, Philippe Lagacé‐Wiens, Kimberly A. Nichol, M. Roussel‐Delvallez, G V Doern, Ronald N. Jones, S. Bouchillon and Heather J. Adam. Their work appears in journals such as Clinical Infectious Diseases, Journal of Clinical Microbiology and The Journal of Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.